Recombinant multi-species IFNA13/Interferon alpha 1/IFNA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFNA13/Interferon alpha 1/IFNA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including lymphocyte activation involved in immune response; response to exogenous dsRNA; and type I interferon-mediated signaling pathway. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: IFN-alpha-1/13,IFNA1,IFNA13,Interferon alpha 1,Interferon alpha-1/13,Interferon alpha-D (LeIF D)

Target products collectionGo to IFNA13/Interferon alpha 1/IFNA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0977-Ag-1/ GM-Tg-hg-SE0977-Ag-2 Human IFNA13/Interferon alpha 1/IFNA1 protein Human
GM-Tg-rg-SE0977-Ag-1/ GM-Tg-rg-SE0977-Ag-2 Rat IFNA13/Interferon alpha 1/IFNA1 protein Rat
GM-Tg-mg-SE0977-Ag-1/ GM-Tg-mg-SE0977-Ag-2 Mouse IFNA13/Interferon alpha 1/IFNA1 protein Mouse
GM-Tg-cynog-SE0977-Ag-1/ GM-Tg-cynog-SE0977-Ag-2 Cynomolgus/Rhesus macaque IFNA13/Interferon alpha 1/IFNA1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0977-Ag-1/ GM-Tg-felg-SE0977-Ag-2 Feline IFNA13/Interferon alpha 1/IFNA1 protein Feline
GM-Tg-cang-SE0977-Ag-1/ GM-Tg-cang-SE0977-Ag-2 Canine IFNA13/Interferon alpha 1/IFNA1 protein Canine
GM-Tg-bovg-SE0977-Ag-1/ GM-Tg-bovg-SE0977-Ag-2 Bovine IFNA13/Interferon alpha 1/IFNA1 protein Bovine
GM-Tg-equg-SE0977-Ag-1/ GM-Tg-equg-SE0977-Ag-2 Equine IFNA13/Interferon alpha 1/IFNA1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0977-Ag-1/ GM-Tg-hg-SE0977-Ag-2; GM-Tg-rg-SE0977-Ag-1/ GM-Tg-rg-SE0977-Ag-2;
GM-Tg-mg-SE0977-Ag-1/ GM-Tg-mg-SE0977-Ag-2; GM-Tg-cynog-SE0977-Ag-1/ GM-Tg-cynog-SE0977-Ag-2;
GM-Tg-felg-SE0977-Ag-1/ GM-Tg-felg-SE0977-Ag-2; GM-Tg-cang-SE0977-Ag-1/ GM-Tg-cang-SE0977-Ag-2;
GM-Tg-bovg-SE0977-Ag-1/ GM-Tg-bovg-SE0977-Ag-2; GM-Tg-equg-SE0977-Ag-1/ GM-Tg-equg-SE0977-Ag-2
Products Name IFNA13/Interferon alpha 1/IFNA1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IFNA13/Interferon alpha 1/IFNA1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFNA13/Interferon alpha 1/IFNA1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.